BioVie advances Parkinson’s, long COVID, and liver disease programs ahead of 2026
Free with Audible trial. Cancel anytime.
Available Worldwide
Quick Facts
| Author | Unknown |
| Narrator | Unknown |
| Runtime | 0h06m |
| Published | December 17, 2025 |
| Rating | 4.5 / 5 (2 ratings) |
| Categories | Business & Careers, Money & Finance, Economics, Personal Finance, Politics & Social Sciences, Politics & Government |
| Format | Audiobook (Digital) |
| Platform | Audible |
About This Audiobook
BioVie CEO Cuong Do joined Steve Darling from Proactive to provide an update on the company’s recent progress across its two lead drug candidates, ...
Why Listen to BioVie advances Parkinson’s, long COVID, and liver disease programs ahead of 2026?
- Expert narration by Unknown brings every character and scene to life across 0h06m of immersive audio.
- Bestseller-quality story from Unknown, rated 4.5 stars by 2 listeners.
- Free with your Audible trial — keep the audiobook forever even if you cancel.
- Perfect for commutes, workouts, and relaxation. Listen anywhere, anytime.
Download: BioVie advances Parkinson’s, long COVID, and liver disease programs ahead of 2026
Some links on this page are affiliate links. If you make a purchase through one of them, we may earn a small commission at no extra cost to you.
BioVie advances Parkinson’s, long COVID, and liver disease programs ahead of 2026 by Unknown is an immersive listening experience. Performed by Unknown with a runtime of 0h06m, you can start with a free trial that you can cancel at any time. The audiobook remains yours forever, even if you end the trial.